DE60217880D1 - Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen - Google Patents

Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen

Info

Publication number
DE60217880D1
DE60217880D1 DE60217880T DE60217880T DE60217880D1 DE 60217880 D1 DE60217880 D1 DE 60217880D1 DE 60217880 T DE60217880 T DE 60217880T DE 60217880 T DE60217880 T DE 60217880T DE 60217880 D1 DE60217880 D1 DE 60217880D1
Authority
DE
Germany
Prior art keywords
nail
nails
dysfunction
disorder
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60217880T
Other languages
English (en)
Other versions
DE60217880T2 (de
Inventor
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trommsdorff GmbH and Co KG
Original Assignee
Trommsdorff GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff GmbH and Co KG filed Critical Trommsdorff GmbH and Co KG
Publication of DE60217880D1 publication Critical patent/DE60217880D1/de
Application granted granted Critical
Publication of DE60217880T2 publication Critical patent/DE60217880T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60217880T 2001-09-04 2002-09-04 Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen Expired - Lifetime DE60217880T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01121200 2001-09-04
EP01121200 2001-09-04
US31831701P 2001-09-12 2001-09-12
US318317P 2001-09-12
PCT/EP2002/009910 WO2003020248A1 (en) 2001-09-04 2002-09-04 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole

Publications (2)

Publication Number Publication Date
DE60217880D1 true DE60217880D1 (de) 2007-03-15
DE60217880T2 DE60217880T2 (de) 2007-11-15

Family

ID=26076707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217880T Expired - Lifetime DE60217880T2 (de) 2001-09-04 2002-09-04 Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen

Country Status (21)

Country Link
EP (1) EP1423100B1 (de)
JP (1) JP2005501883A (de)
KR (1) KR100640039B1 (de)
CN (1) CN1575165A (de)
AT (1) ATE352292T1 (de)
AU (1) AU2002333799B2 (de)
BR (1) BR0212311A (de)
CA (1) CA2459399C (de)
CY (1) CY1106459T1 (de)
CZ (1) CZ2004315A3 (de)
DE (1) DE60217880T2 (de)
DK (1) DK1423100T3 (de)
ES (1) ES2279901T3 (de)
IL (2) IL160552A0 (de)
MX (1) MXPA04002085A (de)
NO (1) NO20040934L (de)
NZ (1) NZ531404A (de)
PL (1) PL205865B1 (de)
PT (1) PT1423100E (de)
RU (1) RU2310441C9 (de)
WO (1) WO2003020248A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615238B2 (en) 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
KR101015546B1 (ko) 2003-08-26 2011-02-16 조선대학교산학협력단 손 발톱용 패취제제
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
JP4704764B2 (ja) * 2005-02-03 2011-06-22 日東電工株式会社 爪貼付用粘着組成物および爪用貼付剤
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
EP1698336A1 (de) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antimykotischezusammensetzungen enthaltend Sertaconazol und entweder Hydrokortison oder einen antibakteriellen Wikrstoff
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
AU2006339842B2 (en) 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
EP2191827B1 (de) 2007-09-05 2013-10-30 Pola Pharma Inc. Antimykotische zusammensetzung
WO2009031644A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌医薬組成物
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
US20090281197A1 (en) * 2008-01-25 2009-11-12 Paul Aaron Kinsinger Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (de) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimykotische pharmazeutische zusammensetzung
EP2431030B1 (de) * 2010-09-17 2015-11-11 Abbell AB Behandlung von Pilzinfektionen
WO2016075962A1 (ja) * 2014-11-10 2016-05-19 正則 原田 陥入爪による創傷を治療するための絆創膏構造体
KR101599260B1 (ko) * 2015-07-30 2016-03-03 (주)우신메딕스 조갑진균증의 예방 또는 치료용 약학 조성물 및 이의 제조방법
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
AU2017301929B2 (en) * 2016-07-27 2023-03-02 Corium Pharma Solutions, Inc. Memantine transdermal delivery systems
JP7469879B2 (ja) 2016-07-27 2024-04-17 コリウム， エルエルシー 経口送達と生物学的に同等である薬物動態を有する経皮送達システム
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
DE102018115272A1 (de) 2018-06-26 2020-01-02 Vinederm GmbH Extraktionsverfahren zur Extraktion von Wirkstoffen aus Teeblättern, Extrakt aus Teeblättern, Herstellungsverfahren für eine Zubereitung, Zubereitung und Pflaster zur topischen Behandlung von Hauterkrankungen
DE102018115270B4 (de) 2018-06-26 2022-07-14 Vinederm GmbH Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
RU2723992C1 (ru) * 2019-11-07 2020-06-18 Марина Леоновна Бельфер Способ и набор для лечения онихокриптоза

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
JPH0665076A (ja) * 1992-08-19 1994-03-08 Pola Chem Ind Inc 抗真菌外用剤
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP3803393B2 (ja) * 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
JPH07309755A (ja) * 1994-05-20 1995-11-28 Nichiban Co Ltd 抗真菌薬貼付剤
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis

Also Published As

Publication number Publication date
NZ531404A (en) 2006-03-31
KR20040031044A (ko) 2004-04-09
CA2459399C (en) 2009-06-30
DK1423100T3 (da) 2007-05-29
BR0212311A (pt) 2004-10-13
CA2459399A1 (en) 2003-03-13
IL160552A (en) 2008-12-29
ES2279901T3 (es) 2007-09-01
NO20040934D0 (no) 2004-03-03
PL205865B1 (pl) 2010-06-30
JP2005501883A (ja) 2005-01-20
RU2004106779A (ru) 2005-04-20
CY1106459T1 (el) 2011-10-12
DE60217880T2 (de) 2007-11-15
IL160552A0 (en) 2004-07-25
NO20040934L (no) 2004-06-04
CZ2004315A3 (cs) 2004-10-13
ATE352292T1 (de) 2007-02-15
RU2310441C2 (ru) 2007-11-20
PL367515A1 (en) 2005-02-21
KR100640039B1 (ko) 2006-10-31
WO2003020248A1 (en) 2003-03-13
CN1575165A (zh) 2005-02-02
EP1423100B1 (de) 2007-01-24
EP1423100A1 (de) 2004-06-02
MXPA04002085A (es) 2004-06-07
RU2310441C9 (ru) 2008-03-10
PT1423100E (pt) 2007-04-30
AU2002333799B2 (en) 2007-09-06

Similar Documents

Publication Publication Date Title
DE60217880D1 (de) Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen
NO20040936D0 (no) Plaster for behandling av dysfunksjoner og forstyrrelser ved neglevekst.
WO2004056307A3 (en) Disease treatment via antimicrobial peptide inhibitors
ITMI20010562A1 (it) Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
CY1111946T1 (el) To (1s, 5s) -3-(5,6-διχλωρο-3-πυριδινυλο)-3, 6-διαζαδικυ-κλο[3.2.0]επτανιο ειναι ενας αποτελεσματiκος αναλγητικος παραγοντας
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
DE60329685D1 (de) Polydextrose induzierte zweiphasige zusammensetzung
WO2002055023A3 (en) Therapeutic film forming composition and treatment system
ATE499929T1 (de) Verwendung eines pflasters zur behandlung von nagelpilzerkrankungen
IL160551A (en) Plaster for the treatment of dysfunctions and disorders of nails
DE60134656D1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
RU2001113050A (ru) Способ лечения скрытых (субклинических) и клинических маститов у коров
UA95094C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства
JO2586B1 (en) Use of different sulfamide derivatives combined with benzo ring for pain management

Legal Events

Date Code Title Description
8364 No opposition during term of opposition